- Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype2020 | First Faculty of Medicine, Second Faculty of Medicine
- Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group2017 | First Faculty of Medicine, Second Faculty of Medicine
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | First Faculty of Medicine
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | Faculty of Physical Education and Sport
- The cellular nuclear matrix regulatory protein YY1 does not directly interact with the mouse polyomavirus large tumor antigen.2001 | Faculty of Science
- The cellular nuclear matrix regulatory protein YY1 does not directly interact with the mouse polyomavirus large tumor antigen.2001 | First Faculty of Medicine, Faculty of Mathematics and Physics
- The preparation of multivalent peptide and glycopeptide dendrimers bearing Tn tumor antigen2001 | Faculty of Science
- Multiple antigen glycopeptides (MAGs) with tumor antigens and incorporated adjuvant: Synthesis and immunobiological activities2002 | Faculty of Science
- Multiple antigen glycopeptides (MAGs) with tumor antigens and incorporated adjuvant: Synthesis and immunobiological activities2002 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia2002 | Second Faculty of Medicine
- Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines2016 | Second Faculty of Medicine
- STUDY OF IMMUNOLOGICAL METHODS IN RELATION TO THE ENERGY METABOLISM OF CANCER CELLS IPublication without faculty affiliation
- The significance of neck lymph nodes in cancerogenesis and spread of tumor2012 | Faculty of Medicine in Hradec Králové
- High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy2017 | Second Faculty of Medicine
- Mitochondrial Dysfunction2009 | First Faculty of Medicine, Third Faculty of Medicine
- Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy2017 | First Faculty of Medicine, Second Faculty of Medicine
- In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients2007 | Second Faculty of Medicine
- Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines2011 | First Faculty of Medicine
- Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer2018 | Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy2013 | Second Faculty of Medicine
- Emerging glyco-based strategies to steer immune responses2021 | Faculty of Science
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response2011 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | Second Faculty of Medicine
- Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells2017 | Second Faculty of Medicine
- Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade2020 | Second Faculty of Medicine
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | First Faculty of Medicine, Third Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
